Loading…

Browse All Grants

99,167 grants found

Filters
Reset

Showing 3,6213,640 of 99,167 grants

Active NON-SBIR/STTR RPGS
Dual targeting chemokine receptors prevents chemotherapy-induced cardiotoxicity
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Louisville United States 2024 – 2028

Doxorubicin (DOX) is an effective chemotherapeutic drug to treat cancer. However, DOX-induced cardiotoxicity (DICT) has limited its use. Dexrazoxane is the only current FDA-approve...

$6.89M
USD
Active NON-SBIR/STTR RPGS
Multi-site photostimulation devices using porosity-based semiconductor heterojunctions for cardiac resynchronization therapy
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOEN... University of Chicago United States 2024 – 2027

Project Summary In cardiovascular disease diagnosis, treatment, and monitoring, a plethora of deformable biointerface devices are utilized. These devices are adept at gauging physi...

$6.07M
USD
Active NON-SBIR/STTR RPGS
Multivalent mRNA-based malaria vaccines
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Drexel University United States 2024 – 2029

The heavy burden of Plasmodium falciparum and Plasmodium vivax malaria drove international efforts to coordinate and integrate tools and programs for mosquito vector control, rapid...

$7.38M
USD
Active NON-SBIR/STTR RPGS
Natural variation underlying extraordinary lifespan
NATIONAL INSTITUTE ON AGING University of Oregon United States 2024 – 2029

Project Summary Aging, particularly the rapid increase in disease prevalence with age, has emerged as one of the top health challenges in the world today. Life expectancy in the Un...

$3.13M
USD
Active NON-SBIR/STTR RPGS
Early Developmental Risk for Adult Cardiovascular Disease: High risk Subgroups, Biomarkers, and Mechanisms
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Brown University United States 2024 – 2028

This project seeks to generate new insights – of clinical and public/health/relevance – regarding the early identification and prevention of adult coronary heart disease (CHD). It...

$13.99M
USD
Active NON-SBIR/STTR RPGS
Cortical Demyelination and Repair in Early Multiple Sclerosis.
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... Icahn School of Medicine At Mount Sinai United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Multiple Sclerosis (MS) is an immune-mediated, demyelinating disorder of the central nervous system (CNS) and a leading cause of disability in young adults...

$6.68M
USD
Active NON-SBIR/STTR RPGS
A Portable, Low-Cost, Pont-of-care Microfluidic System for Rapid Pharmacogenomic Screening of Patients with Major Depressive Disorder
NATIONAL INSTITUTE OF MENTAL HEALTH University of Virginia United States 2024 – 2029

Project Summary/Abstract The current approaches to prescribing medication to patients with major depressive disorder (MDD) involve a‘trial and error’ approach to prescribing select...

$6.95M
USD
Active NON-SBIR/STTR RPGS
Langerhans cells and lymphatic regulation in immunity
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETA... Hospital for Special Surgery United States 2024 – 2029

In systemic lupus erythematosus (SLE), skin pathophysiology is linked to autoimmunity. Patients are photosensitive, able to develop inflammatory skin lesions with even ambient ultr...

$7.89M
USD
Active NON-SBIR/STTR RPGS
Deciphering Molecular Mechanisms of Post-Stroke Depression in Aged Mice
NATIONAL INSTITUTE ON AGING University of Texas Hlth Sci Ctr Houston United States 2024 – 2029

PROJECT SUMMARY Stroke is the leading cause of adult disability. Over the last 20-years, with the decline in stroke mortality due to improvements in acute care, there has been an i...

$7.01M
USD
Active NON-SBIR/STTR RPGS
A novel nuclear role for smooth muscle alpha-actin
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2024 – 2028

ABSTRACT Pathogenic variants in ACTA2, which encodes smooth muscle α-actin (SMA), are a major cause of heritable thoracic aortic disease, and missense variants affecting two specif...

$5.63M
USD
Active NON-SBIR/STTR RPGS
Discovery of small molecules targeting Polycomb repressive complexes 1 and 2
NATIONAL CANCER INSTITUTE University of Southern California United States 2024 – 2027

Discovery of small molecules targeting Polycomb Repressive Complex 1 ABSTRACT: The discovery that mutations and dysregulation of chromatin modifiers are major cancer drivers has in...

$5.64M
USD
Active NON-SBIR/STTR RPGS
Engineering recombinase circuits for cellular diagnostic devices
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOEN... Boston University (Charles River Campus United States 2024 – 2028

Genetically engineered mammalian cells have demonstrated enormous clinical potential, especially as cancer therapy. Also, immune cells equipped with a single-input reporter circuit...

$4.79M
USD
Active NON-SBIR/STTR RPGS
Regulation of phase separation in neuronal heterochromatin
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... University of California, San Diego United States 2024 – 2029

ABSTRACT One of the most astonishing feats in all of biology is the process by which chromatin, the complex of DNA, histone proteins and associated factors, becomes compacted from...

$3.14M
USD
Active NON-SBIR/STTR RPGS
Evaluating the therapeutic potential of hypoxia mimetics in inflammatory demyelinating disease
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... San Diego Biomedical Research Institute United States 2024 – 2029

Multiple sclerosis (MS) is a chronic inflammatory disease that results in demyelination and degeneration of axons in the central nervous system (CNS). Disruption of the blood-brain...

$6.48M
USD
Active NON-SBIR/STTR RPGS
Psychobiological regulation and molecular characterization of cell-free mitochondrial DNA in humans
NATIONAL INSTITUTE OF MENTAL HEALTH Columbia University Health Sciences United States 2024 – 2029

PROJECT SUMMARY Mitochondrial signal transduction is an emerging biological pathway linking adverse psychosocial exposures to disease risk. However, we lack scalable, sensitive, an...

$8.35M
USD
Active NON-SBIR/STTR RPGS
Systems Metabolic Approach for Multi-scale Pancreatic Cancer Phenotyping
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2029

ABSTRACT Pancreatic cancer is an aggressive, painful malignancy with a 5-year survival rate of less than 5% and median survival of about 4 to 24 months. The overall lack of success...

$6.23M
USD
Active NON-SBIR/STTR RPGS
Characterizing gastrointestinal disorder trajectories for autistic sub-groups: Machine learning prediction of risk profiles and response to treatment
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD... University of Southern California United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Gastrointestinal (GI) problems are one of the most common concerns reported by families of autistic children and youth and can have significant lifelong im...

$4.56M
USD
Active NON-SBIR/STTR RPGS
PP2A/B55alpha substrate specificity and function in cell cycle progression
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES Temple University of the Commonwealth United States 2024 – 2029

The goal of this proposal is to fully delineate the molecular mechanisms by which the prominent serine/threonine Protein Phosphatase 2 (PP2A) holoenzyme, specifically PP2A/B55α, re...

$6.62M
USD
Active NON-SBIR/STTR RPGS
Targeting olfactory neural pathways to combat obesity
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Baylor College of Medicine United States 2024 – 2029

PROJECT SUMMARY The sense of smell mainly plays a priming role in eating behavior. Recently, we observed that relatively long time food (chow)-derived odor exposure suppresses both...

$5.43M
USD
Active NON-SBIR/STTR RPGS
Elucidating novel mechanisms for pancreatitis through calcineurin signaling
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Stanford University United States 2024 – 2028

PROJECT SUMMARY. Acute pancreatitis (AP) is an exquisitely painful, life-threatening, public health problem that has substantial morbidity and limited treatment modalities. Our lon...

$6.2M
USD